From: Defining the optimal dose of radiation in leukemic patients with extramedullary lesions
Patients Characteristics | No (%) |
---|---|
Gender | Â |
Male | 11 (45.8) |
Female | 13 (54.2) |
Age, median (range) | 30 (5-69) |
Primary disease | Â |
AML | 18 (75.0) |
ALL | 5 (20.8) |
CML | 1 (4.2) |
Disease pattern | Â |
Before 1st remission | 7 (29.2) |
First manifestation of 1st relapse | 11 (45.8) |
After relapse | 6 (25.0) |
History of SCT (+) | 14 (58.3) |
History of TBI (+) | 9 (37.5) |
Biopsy confirmed (+) | 14 (33.3) |
Tumor site | Â |
Bone | 19 (45.2) |
Soft tissue | 16 (38.1) |
Lymph nodes | 5 (11.9) |
Solid organ | 2 (4.8) |
Initial tumor size (LD), cm median (range) | 4.8 (1.1-15.0) |
Initial tumor size (BP), cm2 median (range) | 10.13 (0.88-54.0) |
Initial tumor volume, cm3 median (range) | 43.3 (1.5-247.5) |
Total | 24 patients, 42 sites |